HWM
AMRX icon

Hemington Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Hemington Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2K Buy
206
+25
+14% +$224 ﹤0.01% 1306
2025
Q2 		$1K Buy
181
+68
+60% +$513 ﹤0.01% 1380
2025
Q1 		$0 Buy
113
+17
+18% +$142 ﹤0.01% 1502
2024
Q4 		$0 Sell
96
-244
-72% -$2.05K ﹤0.01% 1535
2024
Q3 		$2K Buy
+340
New +$2.66K ﹤0.01% 1134

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Hemington Wealth Management's AMRX Position: Q3 2025 in Review

Hemington Wealth Management increased its Amneal Pharmaceuticals (AMRX) stake by 14% in Q3 2025, buying an estimated $224 and bringing the position to 206 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

Hemington Wealth Management first reported a position in AMRX in Q3 2024 and has held it in 5 quarters since. 248 funds tracked by Wall St. Rank hold AMRX as of Q3 2025.

  • Hemington Wealth Management held 206 shares of Amneal Pharmaceuticals worth $2K as of Q3 2025.
  • Hemington Wealth Management bought 25 Amneal Pharmaceuticals shares in Q3 2025, an estimated $224.
  • Amneal Pharmaceuticals made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1306 holding.
  • Hemington Wealth Management first reported a position in Amneal Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 248 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.